• Basemark launched a share offering following its first defense production contract, valued at more than EUR 10 million.
• First deliveries are scheduled for 2027; its automotive business turned profitable in September 2026.
• Defense sales negotiations now cover more than 70 potential customers, up from about 30 in January.
• Allergy vaccine developer Desentum raised EUR 28 million in financing.
• Hycamite secured its second cooperation agreement in September, involving plans for a large balancing power plant in Kotka.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Springvest Oyj published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.